ATE452982T1 - Verfahren zur verabreichng von nukleinsäuren in zellen in vitro oder ex vivo - Google Patents
Verfahren zur verabreichng von nukleinsäuren in zellen in vitro oder ex vivoInfo
- Publication number
- ATE452982T1 ATE452982T1 AT99401687T AT99401687T ATE452982T1 AT E452982 T1 ATE452982 T1 AT E452982T1 AT 99401687 T AT99401687 T AT 99401687T AT 99401687 T AT99401687 T AT 99401687T AT E452982 T1 ATE452982 T1 AT E452982T1
- Authority
- AT
- Austria
- Prior art keywords
- cells
- vitro
- vivo
- administration
- nucleic acids
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13045—Special targeting system for viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13051—Methods of production or purification of viral material
- C12N2740/13052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2810/00—Vectors comprising a targeting moiety
- C12N2810/50—Vectors comprising as targeting moiety peptide derived from defined protein
- C12N2810/60—Vectors comprising as targeting moiety peptide derived from defined protein from viruses
- C12N2810/6045—RNA rev transcr viruses
- C12N2810/6054—Retroviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11328098A | 1998-07-10 | 1998-07-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE452982T1 true ATE452982T1 (de) | 2010-01-15 |
Family
ID=22348556
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT99401687T ATE452982T1 (de) | 1998-07-10 | 1999-07-06 | Verfahren zur verabreichng von nukleinsäuren in zellen in vitro oder ex vivo |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0995802B1 (de) |
JP (1) | JP2000139478A (de) |
AT (1) | ATE452982T1 (de) |
DE (1) | DE69941836D1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9493789B2 (en) * | 2014-04-24 | 2016-11-15 | Miltenyi Biotec Gmbh | Automated generation of genetically modified stem cells |
MA40318A (fr) * | 2014-11-05 | 2017-09-13 | Juno Therapeutics Inc | Procédés de transduction et de traitement de cellules |
EP4342978A2 (de) * | 2016-09-01 | 2024-03-27 | Chimera Bioengineering Inc. | Goldoptimierte car-t-zellen |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5017492A (en) * | 1986-02-27 | 1991-05-21 | Life Technologies, Inc. | Reverse transcriptase and method for its production |
EP0857217B1 (de) * | 1995-10-16 | 2005-04-13 | Dana-Farber Cancer Institute | Neue expressionsvektoren und verfahren zu deren verwendung |
ATE424463T1 (de) * | 1996-05-06 | 2009-03-15 | Oxford Biomedica Ltd | Rekombinationsunfähige retrovirale vektoren |
CA2365655A1 (en) * | 1999-03-15 | 2000-09-21 | Chiron Corporation | Retrovirus producting cells utilizing a high multiplicity of transduction |
-
1999
- 1999-07-06 EP EP99401687A patent/EP0995802B1/de not_active Expired - Lifetime
- 1999-07-06 AT AT99401687T patent/ATE452982T1/de not_active IP Right Cessation
- 1999-07-06 DE DE69941836T patent/DE69941836D1/de not_active Expired - Lifetime
- 1999-07-12 JP JP11198186A patent/JP2000139478A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE69941836D1 (de) | 2010-02-04 |
JP2000139478A (ja) | 2000-05-23 |
EP0995802A2 (de) | 2000-04-26 |
EP0995802B1 (de) | 2009-12-23 |
EP0995802A3 (de) | 2001-01-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69635864D1 (de) | Rekombinante rna-replikase von hepatitis-c-virus | |
DE59912118D1 (de) | Verfahren zur herstellung von genetisch modifizierten cd34-negativen, adhärent wachsenden hämatopoietischen stammzellen | |
ATE237312T1 (de) | In liposomen verkapselte nukleinsäurekomplexe | |
ATE87663T1 (de) | Verfahren zur herstellung von faktor-viii:c-typ- proteinen. | |
DE3752319T2 (de) | Prozess zur rekombinanten Herstellung von HIV-2 - Proteinen sowie Zellen, die HIV-2 - Proteine exprimiert | |
EP0161640A3 (de) | Mit "Vogelretrovirus-Rinderwachstumshormon"-DNS transformierte eingekapselte Mausezellen und Verfahren zum Verabreichen von BGH in vivo | |
DE69720026T2 (de) | Verfahren zur herstellung von d-aminosäuren durch direkte gärung | |
DE3851289D1 (de) | Verfahren zur Züchtung rekombinanter Zellen. | |
ATE278024T1 (de) | Methode zur herstellung von rekombinanten zellen | |
ATE391175T1 (de) | Multidrug resistenz gen | |
DE69131069T2 (de) | Plasmid das für die aminosäuresequenz von tcf-ii kodierende dns enthalt, transformierte zelle und produktion einer physiologisch aktiven substanz mit ihrer verwendung | |
ATE166109T1 (de) | Methode zur genetischen veränderung von knochenmarkzellen von primaten und dafür brauchbare zellen, die rekombinante retrovirale vektoren produzieren | |
ATE339511T1 (de) | Natürliche oder synthetische retroelement- sequenzen, die die insertion von nukleotiden in eukaryotische zellen erlauben | |
CO4410255A1 (es) | Procedimiento para introducir acido nucleico en celulas eucarioticas superiores y medio para transfeccion | |
KR880009991A (ko) | 항혈액응고작용을 갖는 폴리펩티드 | |
ATE452982T1 (de) | Verfahren zur verabreichng von nukleinsäuren in zellen in vitro oder ex vivo | |
DE60038630D1 (de) | Verfahren zur ex vivo bildung von säugetier-knochen und dessen verwendungen | |
DE68929296D1 (de) | Verfahren zur biochemischen Oxidation von Steroiden sowie dafür verwendbare, genetisch manipulierte Zellen | |
DE69425809D1 (de) | Methoden zur Herstellung von Protein C | |
ES2061524T3 (es) | Un vector plasmidico para la expresion en bacillus y empleado para la clonacion del gen estructural que codifica la hormona de crecimiento humana y un metodo para la produccion de la hormona. | |
DE3878410D1 (de) | Verfahren zur erhoehung von gen-expression. | |
ATE339510T1 (de) | Dna-konstrukt zur gewebespezifischen expression eines blutkgerinnungsfaktors | |
ATE341630T1 (de) | Verwendung von pankreatischer procarboxypeptidase b zur herstellung von insulin | |
ES2117203T5 (es) | Procedimiento de produccion de enzima dextranasa y decodificacion de su adn. | |
ATE302282T1 (de) | Erhöhte herstellung von sekretierten proteinen durch rekombinante hefezellen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |